News
The field of injectable neurotoxins is in a growth phase. FDA this year approved Jeuveau (prabotulinumtoxinA-xvfs), a pr…
With Ava Shamban, MD and Jeffrey Dover, MD
Back pain is extremely common, affecting 84 percent of people at some point in life.1 Risk factors for back pain inc…
Gaurav Singh, MD, MPH
The growing trend of medical practices transitioning to cosmetic practices is due in part to a variety of reasons in…
Suneel Chulukuri, MD and Kim Campbell
Patricia Altavilla is the new Chief Executive Officer of Suneva® Medical, Inc.
An industry vet, Altavilla began h…
Protecting the Barrier in Adult Atopic Dermatitis
“I still think it’s so important to remember topica…
When I think of San Francisco dermatologist Vic Narurkar, MD, I don’t think of all of his professional accomplishm…
Jeuveau from Evolus Now FDA Cleared for Aesthetic Injection
The FDA has approved Jeuveau (prabotulinumtoxinA-xvfs) fr…
BD (Becton, Dickinson and Company) has presented BD Hylok,its new glass pre-fillable syringe for the administration of v…
